Acura Pharmaceuticals Forecast and Stock Analysis
Technical ACUR stock analysis for Thursday May 23, 2019.
No changes to the price of Acura Pharmaceuticals in the last trading day ( Thursday, 23rd May 2019 ). During day the stock fluctuated 0.00% from a day low at $0.23 to a day high of $0.23. The price has been going up and down for this period, and there has been a -6.5% loss for the last 2 weeks.
- 30 day high of the ACUR stock price was $0.28 and low was $0.13.
- 90 day high was $0.29 and low was $0.13.
- 52 week high for the Acura Pharmaceuticals - $0.49 and low - $0.06.
Acura Pharmaceuticals lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 4.18% during the next 3 months and, with 90% probability hold a price between $0.17 and $0.29 at the end of this period.
Acura Pharmaceuticals holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $0.21 and $0.21. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday May 22, 2019, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.
Relative Strength Index (RSI)
RSI14 is 48 and the stock is currently not being overbought or oversold
Support & Resistance
On the downside, the stock finds support just below today's level from accumulated volume at $0.21 and $0.18.
There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Acura Pharmaceuticals finds support just below today's level at $0.21. If this is broken, then the next support from accumulated volume will be at $0.18 and $0.18.
This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.00 between high and low, or 0.00%. For the last week the stock has had a daily average volatility of 22.41%.
Our recommended stoploss: $0.22 (-6.04%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from pivot bottom found 1 days ago.)
22.41 %Average volatility
Very Low Low Medium High Very High
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term. We have upgraded our recommendation for this stock since last evaluation from a Hold/Accumulate to a Buy Candidate.
|Golden Star Signal|
Get competitive edge
The signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives a very good return. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Get access to Golden Star list now
|ACUR $0.23 ($0.00 0.00%)|
ACUR is down $0.00 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for ACUR based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the ACUR analysis is free »
From Our Blog
- Trading With Moving Average
- Pivot Points
- Accumulated Volume - Support and Resistance
- Volume - The Indicator You Really Need to Know
- We Give Back!
- Better Buy: Amazon vs. Facebook
- Better Buy: Apple vs. Microsoft
- Relative Strength Index (RSI)
- How to Lose Money When Trading: Part 2
- How to Lose Money When Trading: A Trader is Born
- Our 2017 Christmas Donation
- The Golden Star
- Announcing Partnership With CityFALCON
- Why correct moving average matters
- NASDAQ down -4.17%. Our portfolio is up +8.56%
- New Feature Added: Golden Star Signal
- Pick a Winner With StockInvest.us